ANTIVIRAL THERAPY FOR FACIAL NEUROPATHY ASSOCIATED WITH HERPES SIMPLEX VIRUS TYPE 1
- Authors: Ruzhentsova T.A.1, Khavkina D.A.2, Chukhlyaev P.V.2
-
Affiliations:
- Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
- «REAVIZ» Moscow Medical University
- Issue: No 5 (2017)
- Pages: 56-60
- Section: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/278674
- ID: 278674
Cite item
Open Access
Access granted
Abstract
Previous investigations have shown the value of herpes simplex virus 1 (HSV-1) in the development of nervous system lesions. Lesions of cranial nerves occur in patients of any age and substantially disrupt a patient’s ability to work and quality of life. Facial neuropathy (Bell’s palsy) is most common. This disease is characterized by the high rate of detection of HSV-1 markers and by the efficiency of antiviral therapy. However, the high prevalence of HSV-1 infection in the population, including also among healthy individuals cannot be viewed as convincing evidence for the role of the virus in the development of Bell’s palsy. The paper gives a clinical example of Bell’s palsy developing in a 27-year-old female patient with an exacerbation of HSV-1-induced infection. The treatment with anti-inflammatory and neurotropic drugs in combination with microcirculation-improving agents and non-drug therapy were ineffective. Lower-grade fever, facial asymmetry complaints, and headache persisted after a cycle of treatment. Blood tests showed lymphocytosis and the higher titers of IgM and IgG antibodies to HSV-1. The use of acyclovir resulted in the relief of symptoms.
Keywords
Full Text
About the authors
Tatiana A. Ruzhentsova
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: ruzhencova@gmail.com
МD, Leading Researcher, Clinical Department of Infectious Pathology 3a, Novogireevskaya St., Moscow 111123, Russia
Daria A. Khavkina
«REAVIZ» Moscow Medical University
Email: havkina@gmail.com
Six-Year Student, Faculty of General Medicine
Pavel V. Chukhlyaev
«REAVIZ» Moscow Medical University
Email: pafachka@gmail.com
Six-Year Student, Faculty of General Medicine
References
- Исаков В.А., ред. Герпесвирусные инфекции человека: руководство для врачей. СПб.: СпецЛит, 2013. 670 с.
- Михайлова И.И., Орлова В.А., Минутко В.Л., Малышева И.Н., Елисеева Н.А., Холодняк А.Ю., Кретова Ж.Ю. Сопряженность психопатологической симптоматики и уровня сывороточных антител к вирусам группы герпеса при различных типах течения приступообразной шизофрении. Академический журнал Западной Сибири 2013; 6(49): 99-102.
- Prasad K.M., Eack S.M., Goradia D., Pancholi K.M., Keshavan M.S., Yolken R.H., Nimgaonkar V.L. Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study. Am. J. Psychiatry 2011; 168(8): 822-30. D0I:10.1176/appi.ajp.2011.10101423.
- Shirts B.H., Prasad K.M., Pogue-Geile M.F., Dickerson F, Yolken R.H., Nimgaonkar V.L. Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia. Schizophrenia Research 2008; 106(2-3): 268-74. D0I:10.1016/j.schres.2008.07.017.
- Свистушкин В.М., Славский А.Н. Невропатия лицевого нерва: современные подходы к диагностике и лечению. Русский медицинский журнал 2016; (4): 280-5.
- Невропатия лицевого нерва. В кн.: Одинака М.М., ред. Частная неврология: учебное пособие. М.: МИА, 2009: 110-4.
- Baringer J.R., Swoveland P. Recovery of herpes-simplex virus from human trigeminal ganglions. N. Engl. J. Med. 1973; 288: 648-50. D0I:10.1056/nejm197303292881303.
- Grundfest-Broniatowski S., Broniatowski M., Davies C.R., Jacobs C.B., Tucker H.M., Nose Y. Fine control ofreinnervated muscle. Dynamic rehabilitation of facial paralysis. ASAIO 1989; 35(3): 484-6. D0I:10.1097/00002480-198907000- 00101.
- Yanagihara N. Facial nerve paralysis and its viral etiology. Asian Med. J. 1998; 41(2): 72-6.
- Furuta Y., Takasu T., Sato K.C., Fukuda S., Inuyama Y., Nagashima K. Latent herpes simplex virus type 1 in human geniculate ganglia. Acta Neuropathologica 1992; 84: 39-4. D0I:10.1007/bf00427213.
- McCormick D.P. Herpes-simplex virus as cause of Bell’s palsy. Lancet 1972; 299(7757): 937-9. D0I:10.1016/s0140-6736(72)91499-7.
- Sartoretti-Schefer S., Wichmann W., Valavanis A. Idiopathic, herpetic and HIV-associated facial nerve palsies: abnormal MR enhancement patterns. Am. J. Neuroradiol. 1994; 15: 479-85.
- Johnson R.T., Griffin J.W. eds. Current therapy in Neurologic Disease. 5th ed. St. Louis: Mosby, 1997. 429 p.
- Деконенко Е.П., Леонтьева И.Я., Мартыненко И.Н., Митрофанова И.В., Соколова М.В., Караванов А.С., Прыткова М.И., Соколова М.М., Идрисова Ж.Р. Невриты лицевого нерва и их связь с вирусами герпеса. Журнал неврологии и психиатрии 2000; (6): 58-9.
- Adour K.K., Ruboyianes J.M., Von Doersten P.G., Quesenberry C.P., Byl F.M., Hitchcock T. Bell’s palsy treatment with acyclovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled trial. Ann Otol. Rhin. Laryng. 1996; 105(5): 371-8. D0I:10.1177/000348949610500508.
Supplementary files
